Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Video Education With Result Dependent dIsclosure

Outcome
Finished, no results posted
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
4 August 2022
Ended
1 September 2026
Enrollment
1,334 participants
Sites
1
Primary outcomes
Video Education Acceptability (Qualitative Interview Study)
Sponsor type
Academic / other
Results posted
No
Last update
19 October 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.

Detailed description public domain (ClinicalTrials.gov)

This study consists of two parts: * Qualitative assessment: * This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review. Participation in the study will be considered complete after the interview is finished. The qualitative assessment study will recruit 20 total participants. * The data gathered from this study will inform the refinement and adaptation of the VERDI model for the subsequent randomized controlled trial. * Randomized control trial: * A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling in 1000 participants